NGNE · Neurogene Inc. · Executive Compensation

$35.48 -0.64 (-1.77%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$710.00M

20.01M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rachel McMinn	Founder and Chief Executive Officer	$618,800	$371,280	$385,746	$1,826,570	—	$7,157	$3,209,553
Christine Mikail	President and Chief Financial Officer	$556,000	$305,800	$327,642	$1,552,754	—	$12,262	$2,754,458
Julie Jordan	Chief Medical Officer	$496,800	$198,720	$135,576	$640,392	—	$819	$1,472,307

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Rachel McMinn	Founder and Chief Executive Officer	$595,000	$327,250	—	$2,535,405	—	$7,160	$3,464,815
Christine Mikail	President and Chief Financial Officer	$515,000	$231,750	$1,150,422	$1,465,002	—	—	$3,362,174
Julie Jordan	Chief Medical Officer	$460,000	$184,636	—	$1,809,000	—	$6,400	$2,460,036

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Donna Cochener	Former Interim Chief Executive Officer and General Counsel	$423,581	$219,375	—	—	$264,935	$919,541	$1,827,432
Sean Smith	Former Interim Chief Financial Officer	$384,102	$159,167	—	—	$192,223	$1,074,291	$1,809,783
Christine Mikail	President and Chief Financial Officer	$455,787	$167,502	—	$509,195	—	—	$1,132,484
Rachel McMinn	Founder and Chief Executive Officer	$467,890	$196,514	—	$404,087	—	$12,138	$1,080,629
Stuart Cobb	Chief Scientific Officer NEOs Prior to the Merger	$362,258	$116,549	—	$305,517	—	—	$784,324
Jonathan G. Drachman	Former Chief Executive Officer and President	$113,544	—	—	—	—	$436,439	$549,983

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Donna Cochener	Former Interim Chief Executive Officer and General Counsel	$290,986	—	—	$590,146	$108,247	$4,520	$993,899
Jonathan G. Drachman	Former Chief Executive Officer and President	$452,985	—	—	$251,655	$192,519	$5,020	$902,179
Rachel McMinn	Founder and Chief Executive Officer	$447,741	$205,961	—	—	—	$2,843	$656,545
Christine Mikail	President and Chief Financial Officer	$436,160	$175,554	—	—	—	—	$611,714
Stuart Cobb	Chief Scientific Officer NEOs Prior to the Merger	$341,256	$117,731	—	—	—	—	$458,987

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jonathan G. Drachman	Chief Executive Officer	$137,304	—	—	$3,445,109	$240,625	—	$3,823,038
David J. Main	Former Chief Executive Officer and President	$373,814	—	—	—	—	$1,590,114	$1,963,928
Kamran Alam	Interim Chief Financial Officer and Vice President, Finance	$390,800	—	—	—	—	$809,197	$1,199,997

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David J. Main	Former Chief Executive Officer and President	$535,000	—	—	$3,413,647	$267,500	$10,139	$4,226,286
Kamran Alam	Interim Chief Financial Officer and Vice President, Finance	$365,000	—	—	$1,262,777	$127,750	—	$1,755,527

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David J. Main	Former Chief Executive Officer and President	$510,000	—	—	$2,289,339	$240,975	—	$3,040,314
Kamran Alam	Interim Chief Financial Officer and Vice President, Finance	$335,000	—	—	$989,984	$105,525	—	$1,430,509

Executive changes

Person	Role	Change	Effective	Filed
Christine Mikail	Class II director	Appointed	2026-04-20	2026-04-20
Robert "Keith" Woods	Class II director	Appointed	2025-06-12	2025-06-12
Sarah B. Noonberg	Class II director	Appointed	2025-06-12	2025-06-12

Key facts CIK 1404644 CUSIP 64135M105 13F (30d) 65 filings 65 filers Visit website Investor relations